Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Diseases
Alzheimer's Disease
Dementia
Dementia with Lewy Bodies
Frontotemporal Dementia
Vascular Dementia
Mild Cognitive Impairment
View all Diseases
Topics
Diagnostics
Biology
Biomarkers
Treatment
Clinical Care
Prevention
View all Topics
Conferences
AAIC 2023
BNA 2023
AD/PD 2023
ARUK 2023
CTAD 2022
AAIC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
AAIC 2022 and Biomarkers
View overview page
4:07
Plasma versus neuroimaging biomarkers for Alzheimer’s disease clinical trials
Pamela Lukasewicz Ferreira
• 3 Aug 2022
2:10
Biomarkers of delirium incidence and severity
Sharon K. Inouye
• 2 Aug 2022
4:43
Developing novel digital biomarkers
Rhoda Au
• 11 Aug 2022
2:25
Targeting neuroinflammation: identifying new targets using transcriptomics
Niels Plath
• 9 Aug 2022
0:56
Biomarkers for risk assessment and early diagnosis of AD
Marc Suárez-Calvet
• 26 Jul 2022
2:29
State of microglial and inflammatory markers in the AD field
Niels Plath
• 9 Aug 2022
4:23
Successful Aging after Elective Surgery: goals of the SAGES II study
Sharon K. Inouye
• 2 Aug 2022
1:26
Next steps in dementia biomarkers
Marc Suárez-Calvet
• 26 Jul 2022
2:05
Neuropsychiatric and behavioral markers of dementia risk
Zahinoor Ismail
• 10 Aug 2022
1:26
Directions for blood biomarker research for early AD diagnosis
Marta Milà-Alomà
• 12 Aug 2022
2:23
Progress in the Davos Alzheimer’s Collaborative’s Global Cohort Development program
Rhoda Au
• 11 Aug 2022
3:02
The Davos Alzheimer’s Collaborative
Rhoda Au
• 11 Aug 2022
4:40
Using digital technology to build a truly global cohort in Alzheimer’s disease
Rhoda Au
• 11 Aug 2022
3:01
The promise of reactive astrocytes as biomarkers
Carole Escartin
• 27 Jul 2022
3:19
Prognostic blood biomarkers in the pre-clinical stages of Alzheimer’s disease
Marta Milà-Alomà
• 12 Aug 2022
2:55
Research priorities to achieve widespread use of blood-based biomarkers in Alzheimer’s disease
Pamela Lukasewicz Ferreira
• 3 Aug 2022
1
2
3
Next